Abeona Therapeutics
ABEO
ABEO
107 hedge funds and large institutions have $177M invested in Abeona Therapeutics in 2026 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 33 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2.55% less ownership
Funds ownership: 71.85% → 69.3% (-2.5%)
14% less capital invested
Capital invested by funds: $205M → $177M (-$28.1M)
Holders
107
Holding in Top 10
3
Calls
$8.91M
Puts
$4.45M
Top Buyers
| 1 | +$5.5M | |
| 2 | +$3.14M | |
| 3 | +$2.54M | |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$2.5M |
| 5 |
PBM
Propel Bio Management
Los Angeles,
California
|
+$2.5M |
Top Sellers
| 1 | -$9.71M | |
| 2 | -$3.25M | |
| 3 | -$3M | |
| 4 |
JG
Jain Global
New York
|
-$1.93M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.34M |
